We are live on ! Find out more
CMLTU

CM Life Sciences III Inc. Unit
CMLTU

Delisted

CMLTU was delisted on the 17th of December, 2021.

Back to rankings

57 hedge funds and large institutions have $291M invested in CM Life Sciences III Inc. Unit in 2021 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$35.5M
2
TCIM
TOMS Capital Investment Management
New York
+$23.4M
3
PTC
Petrus Trust Company
Texas
+$19.9M
4
TP
Third Point
New York
+$14M
5
DCM
Driehaus Capital Management
Illinois
+$13.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
26
Dendur Capital
New York
$3.29M +$3.23M +300,000 New
Morgan Stanley
27
Morgan Stanley
New York
$3.23M +$3.18M +295,361 New
ACA
28
Arena Capital Advisors
California
$3.18M +$3.14M +290,820 New
GA
29
Gagnon Advisors
New York
$2.84M +$2.8M +259,710 New
SFM
30
Soros Fund Management
New York
$2.74M +$2.7M +250,000 New
CCM
31
Context Capital Management
California
$2.63M +$2.59M +240,213 New
Marshall Wace
32
Marshall Wace
United Kingdom
$2.19M +$2.16M +200,000 New
CCA
33
Castle Creek Arbitrage
Colorado
$2.18M +$2.16M +200,000 New
6CM
34
683 Capital Management
New York
$1.09M +$1.08M +100,000 New
TD Asset Management
35
TD Asset Management
Ontario, Canada
$1.09M +$1.1M +101,590 New
MS
36
Maven Securities
Jersey
$1.09M +$1.08M +100,000 New
VF
37
Virtu Financial
New York
$844K +$831K +77,032 New
SFM
38
Sphera Funds Management
Israel
$821K +$809K +75,000 New
ZDA
39
Zweig-DiMenna Associates
New York
$820K +$807K +74,874 New
SC
40
Sculptor Capital
New York
$771K +$759K +70,409 New
HF
41
HRT Financial
New York
$570K +$562K +52,118 New
SRF
42
Silver Rock Financial
California
$543K +$539K +50,000 New
LCS
43
Levin Capital Strategies
New York
$496K +$489K +45,318 New
SCM
44
Shaolin Capital Management
Florida
$436K +$430K +39,852 New
Jane Street
45
Jane Street
New York
$398K +$392K +36,316 New
RCM
46
Radcliffe Capital Management
Pennsylvania
$274K +$270K +25,000 New
FTCM
47
First Trust Capital Management
Illinois
$264K +$260K +24,114 New
SC
48
Scholtz & Company
Connecticut
$243K +$239K +22,150 New
HighTower Advisors
49
HighTower Advisors
Illinois
$138K +$136K +12,632 New
Northern Trust
50
Northern Trust
Illinois
$127K +$125K +11,618 New
1
2
3

CMLTU Hedge Fund Activity: Q2 2021 in Review

57 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences III Inc. Unit (CMLTU) for Q2 2021, worth a combined $291M.

Buyers outnumbered sellers: 57 funds opened new CMLTU positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $35.5M.

  • 57 institutional investors held CM Life Sciences III Inc. Unit (CMLTU) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $291M of CM Life Sciences III Inc. Unit stock for Q2 2021.
  • 57 funds opened new CM Life Sciences III Inc. Unit positions in Q2 2021 and 0 closed out, a net change of +57 holders.
  • The largest CM Life Sciences III Inc. Unit buyer in Q2 2021 was T. Rowe Price Associates, an estimated $35.5M added.

Based on aggregated 13F filings for Q2 2021.